BlackRock Fund Advisors’s Capricor Therapeutics CAPR Stock Holding History

BlackRock Fund Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$44K	Buy	1,660 +69	+4%	+$2.07K	﹤0.01%	3783
2016 Q3	$52K	Buy	1,591 +5	+0.3%	+$188	﹤0.01%	3770
2016 Q2	$63K	Sell	1,586 -23	-1%	-$812	﹤0.01%	3776
2016 Q1	$41K	Sell	1,609 -89	-5%	-$2.16K	﹤0.01%	3844
2015 Q4	$52K	Buy	+1,698	New	+$67.5K	﹤0.01%	3865

Other funds holding CAPR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

CBA

Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FWM

Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock Fund Advisors's CAPR Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Capricor Therapeutics (CAPR) stake by 4.3% in Q4 2016, buying an estimated $2.07K and bringing the position to 1,660 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #3783.

BlackRock Fund Advisors first reported a position in CAPR in Q4 2015 and has held it in 5 quarters since. The position peaked at $63K in Q2 2016. 20 funds tracked by Wall St. Rank hold CAPR as of Q4 2016.

BlackRock Fund Advisors held 1,660 shares of Capricor Therapeutics worth $44K as of Q4 2016.
BlackRock Fund Advisors bought 69 Capricor Therapeutics shares in Q4 2016, an estimated $2.07K.
Capricor Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3783 holding.
BlackRock Fund Advisors first reported a position in Capricor Therapeutics in Q4 2015 and has held it in 5 quarters since.
BlackRock Fund Advisors's Capricor Therapeutics position peaked at $63K in Q2 2016.
20 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.